Publicly traded commercial pharmaceutical company (Nasdaq: IRWD) dedicated to making a difference for those living with gastrointestinal diseases

RSM/McGladrey is the nation's 5th largest CPA firm and focuses on meeting the assurance, tax, and consulting needs of mid-sized companies. Managed financial statement audit, review, and consulting engagements for middle-market companies in diverse industries, including technology, life sciences, real estate/hospitality, and professional services. Clients were primarily private-equity funds and portfolio companies. Supplemented leadership of complex audit engagements with various consulting and assurance engagements, including M&A due diligence, US GAAP technical accounting consulting and memo preparation, IFRS implementations for US-based multinationals, SAS 70/SOC1 reports, internal control consulting reviews, AUP engagements, and employee benefit plan audits.Rotation in Transaction Advisory Services consulting practice (2012). Performed M&A buy-side and sell-side due diligence engagements and related consulting projects (e.g., carve-outs). Identified key deal issues and performed quality of earnings and working capital adjustments.Rotation in Sarbanes-Oxley consulting practice (2005-2006). In-charged outsourced internal audit function for publicly traded pharmaceutical company for four quarters prior to sale. Developed and implemented test plans and consulted on various internal control design matters.